國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Management of periprosthetic joint i...

Kuhn, Klaus-Dieter.

Management of periprosthetic joint infectiona global perspective on diagnosis, treatment options, prevention strategies and their economic impact /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Management of periprosthetic joint infectionedited by Klaus-Dieter Kuhn.
其他題名:	a global perspective on diagnosis, treatment options, prevention strategies and their economic impact /
其他作者:	Kuhn, Klaus-Dieter.
出版者:	Berlin, Heidelberg :Springer Berlin Heidelberg :2018.
面頁冊數:	xviii, 366 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Artificial jointsInfections.
電子資源:	http://dx.doi.org/10.1007/978-3-662-54469-3
ISBN:	9783662544693$q(electronic bk.)

Management of periprosthetic joint infectiona global perspective on diagnosis, treatment options, prevention strategies and their economic impact /
Management of periprosthetic joint infectiona global perspective on diagnosis, treatment options, prevention strategies and their economic impact /[electronic resource] :edited by Klaus-Dieter Kuhn. - Berlin, Heidelberg :Springer Berlin Heidelberg :2018. - xviii, 366 p. :ill., digital ;24 cm.

From the contents: 1. Introduction -- 2. Economic -- 3. Clinical Aspects -- 4. Diagnosis -- 5. Prevention -- 6. Treatment -- 7. ALBC -- 8. Spacer -- 9. Coating.

Periprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved. For the patient concerned, it is necessary to promptly work out an adequate therapy solution to fight off the infection. Both the clinical experience of the surgeon and the proper diagnostic processes are prerequisite for the reliable detection and identification of an infection. The microbiologist is responsible for identifying the causative germs by screening the patient's synovial fluid and tissue samples. Based on the findings and subsequent resistance testing, the infectious disease specialist can recommend the appropriate antibiotic therapy. Furthermore, the clinical pharmacist is consulted regularly throughout the therapy to discuss the risk of potential drug interactions. The surgeon will proceed with the revision surgery, following defined algorithms. Adequate radical debridement of infected and necrotic surrounding tissue is the most important step towards a successful cure of the infection. Accompanying the surgery, anti-infective agents are given systemically and locally. While systemic application of anti-infectives mainly reduces the number of haematogenic-spreading planktonic germs, local application immediately forms a colonization barrier and protects the implant from sessile biofilm formation. Concurrently, antibiotics are actively released from the implant, resulting in local germ reduction. Thus, local agents are embedded in the concept of surgical PJI treatment as a reliable adjuvant measure and they sustainably support the successful outcome. In one-stage procedures, local agents are released from specialized antibiotic-loaded bone cements, while in two- or multi-stage procedures, local agents are released from corresponding temporary spacers (interim prostheses) Even from an economic standpoint, the combination of systemic and local agent application is meaningful. Furthermore, there are some interesting trends towards the coating of metallic implants to protect against biofilm formation on the implant surface. On the basis of their personal experience, specialists from all over the world present, explain and discuss preventive approaches, appropriate diagnostic strategies for detection, reproducible effective surgical treatments as well as the economic impact of PJI. The reader can use this book as a solid platform for comparing their own approach to PJI treatment with the specialists' recommendations.

ISBN: 9783662544693$q(electronic bk.)

Standard No.: 10.1007/978-3-662-54469-3doiSubjects--Topical Terms:

675530
Artificial joints
--Infections.

LC Class. No.: RD686

Dewey Class. No.: 617.580592

Management of periprosthetic joint infectiona global perspective on diagnosis, treatment options, prevention strategies and their economic impact /
LDR:03786nmm a2200313 a 4500 001 528355
003 DE-He213
005 20180605093831.0
006 m d
007 cr nn 008maaau
008 181024s2018 gw s 0 eng d
020 $a 9783662544693$q(electronic bk.)
020 $a 9783662544686$q(paper)
024 7 $a 10.1007/978-3-662-54469-3 $2 doi
035 $a 978-3-662-54469-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RD686
072 7 $a MNS $2 bicssc
072 7 $a MED065000 $2 bisacsh
082 0 4 $a 617.580592 $2 23
090 $a RD686 $b .M266 2018
245 0 0 $a Management of periprosthetic joint infection $h [electronic resource] : $b a global perspective on diagnosis, treatment options, prevention strategies and their economic impact / $c edited by Klaus-Dieter Kuhn.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2018.
300 $a xviii, 366 p. : $b ill., digital ; $c 24 cm.
505 0 $a From the contents: 1. Introduction -- 2. Economic -- 3. Clinical Aspects -- 4. Diagnosis -- 5. Prevention -- 6. Treatment -- 7. ALBC -- 8. Spacer -- 9. Coating.
520 $a Periprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved. For the patient concerned, it is necessary to promptly work out an adequate therapy solution to fight off the infection. Both the clinical experience of the surgeon and the proper diagnostic processes are prerequisite for the reliable detection and identification of an infection. The microbiologist is responsible for identifying the causative germs by screening the patient's synovial fluid and tissue samples. Based on the findings and subsequent resistance testing, the infectious disease specialist can recommend the appropriate antibiotic therapy. Furthermore, the clinical pharmacist is consulted regularly throughout the therapy to discuss the risk of potential drug interactions. The surgeon will proceed with the revision surgery, following defined algorithms. Adequate radical debridement of infected and necrotic surrounding tissue is the most important step towards a successful cure of the infection. Accompanying the surgery, anti-infective agents are given systemically and locally. While systemic application of anti-infectives mainly reduces the number of haematogenic-spreading planktonic germs, local application immediately forms a colonization barrier and protects the implant from sessile biofilm formation. Concurrently, antibiotics are actively released from the implant, resulting in local germ reduction. Thus, local agents are embedded in the concept of surgical PJI treatment as a reliable adjuvant measure and they sustainably support the successful outcome. In one-stage procedures, local agents are released from specialized antibiotic-loaded bone cements, while in two- or multi-stage procedures, local agents are released from corresponding temporary spacers (interim prostheses) Even from an economic standpoint, the combination of systemic and local agent application is meaningful. Furthermore, there are some interesting trends towards the coating of metallic implants to protect against biofilm formation on the implant surface. On the basis of their personal experience, specialists from all over the world present, explain and discuss preventive approaches, appropriate diagnostic strategies for detection, reproducible effective surgical treatments as well as the economic impact of PJI. The reader can use this book as a solid platform for comparing their own approach to PJI treatment with the specialists' recommendations.
650 0 $a Artificial joints $x Infections. $3 675530
650 0 $a Orthopedic implants $x Complications. $3 800652
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Orthopedics. $3 275845
700 1 $a Kuhn, Klaus-Dieter. $3 384710
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-54469-3
950 $a Medicine (Springer-11650)